DK131576C - Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner - Google Patents

Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner

Info

Publication number
DK131576C
DK131576C DK527668A DK527668A DK131576C DK 131576 C DK131576 C DK 131576C DK 527668 A DK527668 A DK 527668A DK 527668 A DK527668 A DK 527668A DK 131576 C DK131576 C DK 131576C
Authority
DK
Denmark
Prior art keywords
androstanes
oxa
halogen
substituted
preparing
Prior art date
Application number
DK527668A
Other languages
English (en)
Other versions
DK131576B (da
Inventor
M R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK131576B publication Critical patent/DK131576B/da
Application granted granted Critical
Publication of DK131576C publication Critical patent/DK131576C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK527668A 1967-11-03 1968-10-30 Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner DK131576C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
DK131576B DK131576B (da) 1975-08-04
DK131576C true DK131576C (da) 1976-01-05

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527668A DK131576C (da) 1967-11-03 1968-10-30 Analogifremgangsmade til fremstilling af 6-halogensubstituerede 4-oxa-androstaner

Country Status (14)

Country Link
AT (2) AT297236B (da)
BE (1) BE723189A (da)
BR (1) BR6803654D0 (da)
CH (1) CH505855A (da)
DK (1) DK131576C (da)
ES (1) ES359842A1 (da)
FI (1) FI48098C (da)
FR (2) FR1605466A (da)
GB (1) GB1247022A (da)
IE (1) IE33567B1 (da)
IL (1) IL30879A (da)
NL (1) NL6815623A (da)
NO (1) NO132101C (da)
SE (1) SE352360B (da)

Also Published As

Publication number Publication date
NO132101B (da) 1975-06-09
DE1805857A1 (de) 1969-06-26
FR8435M (da) 1971-07-15
FR1605466A (da) 1976-05-14
NO132101C (da) 1975-09-17
DE1805857B2 (de) 1977-06-23
NL6815623A (da) 1969-05-06
AT287932B (de) 1971-02-10
BR6803654D0 (pt) 1973-01-16
FI48098B (da) 1974-02-28
BE723189A (da) 1969-04-30
IL30879A (en) 1972-11-28
CH505855A (de) 1971-04-15
IE33567L (en) 1969-05-03
FI48098C (fi) 1974-06-10
IL30879A0 (en) 1968-12-26
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
DK131576B (da) 1975-08-04
IE33567B1 (en) 1974-08-21
SE352360B (da) 1972-12-27
AT297236B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
DK137232B (da) Analogifremgangsmåde til fremstilling af phenylethanolaminer.
DK122222B (da) Fremgangsmåde til fremstilling af alk-3-en-1-oler.
DK124080B (da) Fremgangsmåde til fremstilling af D-6-metyl-8-cyanmetylergolin.
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
DK119111B (da) Fremgangsmåde til fremstilling af oxazolidinonderivater.
DK118081B (da) Fremgangsmåde til fremstilling af isoksazolderivater.
DK131936C (da) Analogifremgangsmade til fremstilling af 5-phenyl-1h-1,5-benzodiazepin-2,4-dioner
DK119307B (da) Fremgangsmåde til fremstilling af ketonitriler.
DK122758B (da) Fremgangsmåde til fremstilling af α-methyl-multicyclo-methylaminer.
DK115766B (da) Analogifremgangsmåde til fremstilling af thiocarbamidderivater.
DK131821C (da) Analogifremgangsmade til fremstilling af en 2-karbalkoksyaminobenzimidazol
DK122522B (da) Fremgangsmåde til fremstilling af dichlorquinoliner.
DK123100B (da) Fremgangsmåde til fremstilling af N-tritylimidazoler.
DK119663B (da) Analogifremgangsmåde til fremstilling af 2-benzolsulfonamidopyrimidinforbindelser.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK120598B (da) Analogifremgangsmåde til fremstilling af furazanderivater.
DK135287B (da) Analogifremgangsmåde til fremstilling af styrylthiazoliumsalte.
DK125285B (da) Analogifremgangsmåde til fremstilling af furazanderivater.
DK119976B (da) Analogifremgangsmåde til fremstilling af 18-methyl-19-nor-17α-hydroxyprogesteroner og -17-estere deraf.
DK136648C (da) Analogifremgangsmaade til fremstilling af sulfanilamider
DK131994C (da) Analogifremgangsmade til fremstilling af 6alfa,9alfa-difluorprednisolon 17,21-diestere
DK144941C (da) Fremgangsmaade til fremstilling af d-trans-pyrethrinsyre
DK117568B (da) Analogifremgangsmåde til fremstilling af ftalazino-ftalazindioner.
DK122666B (da) Analogifremgangsmåde til fremstilling af hydrocortison-17-cyclopentancorboxylat.
DK132495C (da) Analogifremgangsmade til fremstilling af benzophenoner